ETERNAL is involved in precision fermentation to produce high-quality ingredients for sustainable food production using proprietary protein technology. The company focuses on creating nutritious, animal-free food sources with superior nutritional profiles, utilizing AI to optimize fermentation processes.

ETERNAL

Symbeeosis is involved in the sale of organic tea, organic honey and nutritional supplements. It aims to promote health and wellness through natural ingredients.

Symbeeosis

Eternal | 2,470 followers on LinkedIn. 100% animal free fungal base food, with amazing health and nutritional properties. | Eternal is solving the absence of a properly sustainable and cost-effective protein ingredient that is flavor neutral. The company uses AI and computer vision to improve the fungi fermentation techniques of existing and approved strains. The result is a market-ready product that suits better the needs of a range of food manufacturers, reducing the amount of post processing needed for an end product.

Entrepreneur | Investor

Alejandro Antalich

Suppy Chain Management, Operations & Logistics at Eternal Bioworks

Julia Stanisz

VP Strategic Partnerships at Nomade People | Founder Spinoza.co

Aito De la Rua

Co-Founder and CIO at Eternal

Lucas Gago

Eternal

We’re proud to announce that Eternal is a finalist in the #XPRIZEFeedTheNextBillion competition. We’re thrilled to advance to the finals stage and help create new pathways for environmentally sustainable alternative chicken products to meet consumer demand. Learn more about XPRIZE Feed the Next Billion here. https://lnkd.in/gmDFgPp

“XPRIZE helped us push our ambition and try to reach a global scale.” - #XPRIZEFeedTheNextBillion finalist Eternal As we get ready for XPRIZE Feed the Next Billion finals, learn how biotechnology company Eternal democratizes access to protein around the world through their alternative chicken breast made primarily from their specialized base product: Mycofood. Mycofood is an animal-free biomass developed from nutrient-rich Fusarium venenatum–an FDA and EFSA-approved fungus. By using analytic AI and microprotein cultivation technology, Eternal has made many strides with their technology including accelerating research, optimizing production, and reducing land usage compared to traditional chicken farming by 89%. Learn more about their work here. https://lnkd.in/gwrkiyVW

XPRIZE

Starting the long journey home from FFT gives me time to reflect on what I saw and learned. It was great to hear so many of the largest organisations, both CPG and Food Service talk about the importance of Positive Nutrition. It’s not enough to take the bad stuff out, we need to put the good stuff in which is a a great opportunity for Eternal What really struck me though was the amount and variation of companies developing new foods via fermentation, and the consensus around the lack of scale up and full scale CDMO infrastructure. There was genuine excitement when I shared the plans and capabilities of Synbio and Immensa! If I missed you at the show but you want to learn more about either get in touch.

Mark Fielding

Amazing event at MISTA tonight, so many inspirational people trying to change our food system for the better. I really should have done more science in school.

Mark your calendars we'll be at Future Future Food-Tech in San Francisco on March 21-22. Our own Mark Fielding will be joining a panel to discuss how life-cycle assessment will pioneer the future of alternative proteins, learn more here. https://lnkd.in/g_VY65V @XPRIZE #XPRIZEFeedTheNextBillion

Our own Miguel Neumann was delighted to take part in this Podcast

Metric
Company Name	ETERNAL	Symbeeosis
Symbol
MSH ID	BIO:ETERNAL	COM:SYMBEEOSIS
Market	PRIVATE	PRIVATE
Sector	Consumer Goods	Consumer Goods
Industry	Food Technology	Food & Beverage
Country	US	GR
Stage
Employee Count	1	1
Website	eternal.bio	symbeeosis.com
LinkedIn	eternalbio	symbeeosis
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	87
Web Traffic Growth	5.85
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ETER

BIO:ETERNAL

ETERNAL

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue